Prakiraan wutah bathi resik saben saham kanggo taun ngarep Intensity Therapeutics, Inc. (INTS)
The development of cancer immunotherapy is independent of economic cycles, as demand for tumor treatment remains stable. Intensity Therapeutics (INTS) currently prices in this trend through its projected EPS growth for the coming year, where the parameter equals 39.60. The project relies on transparent INT230-6 tests and management expertise; however, financial stability is currently based on investments, as operating cash flow has not yet been established.
Rincian metrik lan analitis perusahaan Intensity Therapeutics, Inc. (INTS)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- rincian nilai buku perusahaan:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Intensity Therapeutics|INTS - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Intensity Therapeutics Inc|INTS - Tanggungan utang total perusahaan|Utang marang nilai buku Intensity Therapeutics|INTS - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Intensity Therapeutics|Rasio cepet intensitytherapeutics.com
- statistik bathi lan rasio pasar:
INTS - Penghasilan resik perusahaan|Bathi sing dikarepake Intensity Therapeutics|INTS - Nilai perusahaan marang bathi resik|Pangali Forward P/E Intensity Therapeutics Inc|INTS - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Intensity Therapeutics|INTS - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Intensity Therapeutics|INTS - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan intensitytherapeutics.com|INTS - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Intensity Therapeutics
Analisis kabeh metrik perusahaan:Intensity Therapeutics
The scaling of intratumoral drugs by Intensity Therapeutics (INTS) activates operating leverage, allowing revenue to effectively offset R&D capital expenditures. This metric aggregates expert earnings forecasts for the upcoming period, filtering out short-term volatility to identify the true profitability trend. The positive vector of this forward-looking net income trend assessment confirms the resilience of the business model and the reduction of liquidity risks as product lines expand.
Pesaing langsung
Prakiraan wutah bathi resik saben saham kanggo taun ngarep ImmunityBio Corp|Prakiraan wutah bathi saben saham kanggo taun ngarep Immunocore Corp (IMCR)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Janux Therapeutics (JANX)|Prakiraan wutah bathi saben saham kanggo taun ngarep arcusbio.com RCUS|Zymeworks - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Tango Therapeutics Inc TNGX|IOVA - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMTX (Immatics Biotechnologies) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Xencor, Inc. (XNCR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep compasstherapeutics.com (CMPX)|Prakiraan wutah bathi saben saham kanggo taun ngarep REPL|LYEL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep IPHA (Innate Pharma, S.A.)|Proyeksi tambahing bathi saben saham ing taun ngarep PYXS|Prakiraan wutah bathi kanggo taun ngarep CGEN (Compugen)|Dinamika bathi saben saham sing diarepake ing taun ngarep IOBT|Sutro Biopharma - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep MiNK Therapeutics Inc.|werewolftx.com (HOWL) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Immix Biopharma - Dinamika bathi saben saham sing diarepake ing taun ngarep|ALXO (ALX Oncology Holdings) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep cuebiopharma.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PDS Biotechnology (PDSB)|SONN: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|MAIA Biotechnology Inc - Prakiraan wutah bathi saben saham kanggo taun ngarep|Liminatus (LIMN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Lava Tx - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep nextcure.com NXTC|leaptx.com (LPTX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep SNSE|Prakiraan wutah bathi saben saham kanggo taun ngarep TOVX|GRTS (Gritstone Bio) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep KA|NEXI - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Turnstone Biologics Corp. TSBX|VCNX: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|HARP - Prakiraan wutah bathi resik saben saham kanggo taun ngarep
